Anel Berna,Luis Alberto | Leucemia | Innovative Research Award

Published on by Oncology

Innovative Research Award

Luis Alberto Anel Bernal
University of Zaragoza, Spain

Luis Alberto Anel Bernal
Affiliation University of Zaragoza
Country Spain
Google Scholar ID View Profile
Documents 220
Citations 26,035
h-index 56
Subject Area Leucemia
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0002-5175-8394

The Innovative Research Award recognizes distinguished academic researchers whose scholarly activities have significantly contributed to scientific advancement within their respective disciplines. Luis Alberto Anel Bernal of the University of Zaragoza has established an internationally recognized research profile through sustained contributions to leukemia research, translational biomedical science, and interdisciplinary collaboration. His scholarly output reflects a commitment to advancing knowledge through rigorous experimentation, evidence-based methodologies, and international scientific cooperation.[1]

Abstract

Luis Alberto Anel Bernal is recognized for his extensive scientific contributions to leukemia and oncology research through high-impact publications, collaborative investigations, and translational biomedical studies. His research combines molecular biology, clinical investigation, and innovative therapeutic approaches to improve understanding of hematological malignancies. The measurable influence of his scholarly work is reflected through a substantial number of peer-reviewed publications, international collaborations, and a citation record demonstrating long-term academic relevance. These achievements support recognition through the Innovative Research Award as an acknowledgment of sustained scientific excellence and impactful research contributions.[1]

Keywords

Leukemia Research, Cancer Biology, Translational Medicine, Biomedical Science, Oncology, Clinical Research, Scientific Innovation, Molecular Biology, Hematological Malignancies, Precision Medicine, Therapeutic Development, International Collaboration.

Introduction

Modern oncology increasingly depends upon interdisciplinary collaboration, advanced molecular research, and evidence-based clinical investigation to improve patient outcomes. Researchers who consistently contribute high-quality scientific discoveries play an essential role in expanding medical knowledge and supporting the development of innovative therapeutic strategies. Luis Alberto Anel Bernal has participated extensively in this evolving research landscape through decades of scholarly activity focused on leukemia and related biomedical disciplines.[2]

Research Profile

Luis Alberto Anel Bernal is affiliated with the University of Zaragoza, Spain, where he has established an internationally recognized academic career in biomedical sciences with particular emphasis on leukemia research and oncology. His scientific activities encompass experimental investigation, translational medicine, molecular biology, and interdisciplinary collaboration aimed at improving the understanding of cancer development and therapeutic interventions. His academic profile reflects continuous participation in high-quality research initiatives and international scientific partnerships.[1]

Research Contributions

Professor Bernal has contributed significantly to advancing knowledge in leukemia biology through studies investigating molecular signaling pathways, disease progression, cellular regulation, and mechanisms associated with cancer development. His research combines laboratory experimentation with clinically relevant applications, allowing scientific discoveries to support improvements in diagnostic procedures and therapeutic strategies.[4]

Publications

The scholarly publication portfolio of Luis Alberto Anel Bernal demonstrates consistent productivity across peer-reviewed international journals. His publications address diverse aspects of leukemia, oncology, molecular medicine, and biomedical research while contributing valuable scientific evidence to the broader medical literature. The cumulative impact of these publications is reflected through extensive citation activity and continued relevance within contemporary cancer research.[2]

Research Impact

The scientific contributions of Luis Alberto Anel Bernal have generated substantial international academic recognition through a sustained record of peer-reviewed publications and scholarly citations. His work has influenced numerous studies within leukemia research, cancer biology, translational medicine, and molecular oncology. The extensive citation count demonstrates that his research continues to serve as an important scientific resource for investigators, clinicians, and graduate researchers working in oncology-related disciplines.[2]

Award Suitability

The Innovative Research Award recognizes researchers whose sustained scientific excellence has significantly advanced their discipline through impactful research, international collaboration, and measurable scholarly influence. Based on publicly available academic indicators, Luis Alberto Anel Bernal demonstrates these characteristics through his extensive publication record, citation performance, and continued contributions to leukemia and oncology research.[1]

Conclusion

Luis Alberto Anel Bernal has established a distinguished academic profile characterized by consistent scholarly productivity, extensive international collaboration, and substantial scientific impact within leukemia research. His work continues to support advances in biomedical science while contributing valuable knowledge to the global oncology community. The breadth of his research achievements and sustained academic influence make him an appropriate candidate for recognition through the Innovative Research Award.[3]

References

  1. Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S, Anel, A. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1–382.
    https://doi.org/10.1080/15548627.2020.1797280
  2. Martínez-Lostao, L., Anel, A., & Pardo, J. (2015). How do cytotoxic lymphocytes kill cancer cells? Clinical Cancer Research, 21(22), 5047–5056.
    https://doi.org/10.1158/1078-0432.CCR-15-0685
  3. Richieri, G. V., Anel, A., & Kleinfeld, A. M. (1993). Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry, 32(29), 7574–7580.
    https://pubmed.ncbi.nlm.nih.gov/8338853/
  4. De Miguel, D., Lemke, J., Anel, A., Walczak, H., & Martínez-Lostao, L. (2016). Onto better TRAILs for cancer treatment. Cell Death & Differentiation, 23(5), 733–747.
    https://doi.org/10.1038/cdd.2015.174
  5. Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., & Piñeiro, A. (1999). Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. The Journal of Immunology, 163(3), 1274–1281.
    https://pubmed.ncbi.nlm.nih.gov/10415024/

 

Okechukwu Obulezi | Blood Cancer | Best Paper Award

Published on by Oncology

Dr. Okechukwu Obulezi | Blood Cancer | Best Paper Award 

Lecturer | Nnamdi Azikiwe Univeristy | Nigeria

Dr. Okechukwu Jeremiah Obulezi, Ph.D., is a distinguished statistician whose academic trajectory, research productivity, and multidisciplinary impact make him exceptionally suitable for a Best Paper Award. With a strong foundation in Statistics from Nnamdi Azikiwe University and Abia State Polytechnic, culminating in a Ph.D. focused on developing innovative generalized distribution families through Logistic-X transformations, he has consistently advanced statistical theory and its applications. His research interests span probability distributions, machine learning models, survival analysis, competing risks, acceptance sampling, optimum sampling, mask data and censoring schemes—areas crucial to modern data-driven decision-making in engineering, biomedical sciences, public health, and socio-economic modelling. Dr. Obulezi’s publication record is extensive and impactful, with over forty peer-reviewed journal articles in reputable outlets such as Heliyon, Scientific African, Alexandria Engineering Journal, Entropy, Symmetry, AIP Advances, and Earthline Journal of Mathematical Sciences. His works introduce new probability distributions, propose enhanced estimation techniques, develop sampling plans, and apply machine learning to real-world problems such as financial volatility, disease survival modelling, COVID-19 mortality, rainfall analysis, transportation cost prediction, and biomedical datasets. His methodological sophistication and ability to translate theory into practical applications underscore his scholarly depth. Professionally, he serves as Lecturer I at Nnamdi Azikiwe University and holds several academic leadership roles, including Seminar & Project Coordinator and member of multiple university committees. His international academic influence is further demonstrated through active service as a reviewer for renowned journals under Springer, Elsevier, Taylor & Francis, and Scopus-indexed platforms. Dr. Obulezi’s conference contributions and book chapter reviews further affirm his commitment to advancing statistical knowledge. Collectively, his robust research output, innovative contributions to distribution theory, interdisciplinary relevance, and sustained scholarly engagement establish him as a highly deserving candidate for the Best Paper Award.

Profile: Google Scholar 

Featured Publications

  1. Onyekwere, C. K., & Obulezi, O. J. (2022). Chris-Jerry distribution and its applications. Asian Journal of Probability and Statistics, 20(1), 16–30.

  2. Chinedu, E. C. Q., Chukwudum, Q. C., Alsadat, N., Obulezi, O. J., Almetwally, E. M., & Others. (2023). New lifetime distribution with applications to single acceptance sampling plan and scenarios of increasing hazard rates. Symmetry, 15(10), 1–33.

  3. Orji, G. O., Etaga, H. O., Almetwally, E. M., Igbokwe, C. P., Aguwa, O. C., & Obulezi, O. J. (2025). A new odd reparameterized exponential transformed-X family of distributions with applications to public health data. Innovation in Statistics and Probability, 1(1), 88–118.

  4. Obulezi, O. J., Anabike, I. C., Oyo, O. G., Harrison, E., & Perpetua, I. C. (2023). Marshall-Olkin Chris-Jerry distribution and its applications. International Journal of Innovative Science and Research Technology, 8(5), 1–15.

  5. Anabike, I. C., Igbokwe, C. P., Onyekwere, C. K., & Obulezi, O. J. (2023). Inference on the parameters of Zubair-Exponential distribution with application to survival times of guinea pigs. Journal of Advances in Mathematics and Computer Science, 38(7), 12–35.

By creating forward-looking statistical frameworks with real-world applications, the nominee’s research bridges science and society, enabling smarter policies, stronger industries, and transformative technological progress.

Dr. Jun He | Stem Cell Therapy | Best Researcher Award

Published on by Oncology

Dr. Jun He | Stem Cell Therapy | Best Researcher Award

The First Affiliated Hospital of Soochow University |  China

Author Profile

Scopus

Dr. Jun He appears to be a highly suitable candidate for the Research for Community Impact Award based on several key factors:

Extensive Professional Experience:

  • Leadership: Dr. He has been the Director of the HLA typing laboratory at the Jiangsu Institute of Hematology since 2010. This role indicates a significant leadership position within an influential research institution.
  • Long-term Commitment: Dr. He has held continuous positions of increasing responsibility at the same institution since 1985, showcasing dedication and consistent contribution to his field.

Educational Background:

  • Dr. He has a robust educational foundation in medicine, with both an M.D. and a B.S. from prestigious institutions in China (Soochow University and Suzhou Medical College).

Impactful Research:

  • Publication Record: Dr. He has published extensively in reputable peer-reviewed journals, with 33 listed publications. These papers cover critical aspects of HLA typing, stem cell transplantation, immunogenetics, and related fields, demonstrating significant contributions to medical science and community health.
  • Research Focus: His research on the genetic loci of HLA, KIRs, and their impact on transplantation outcomes is crucial for improving the success rates and safety of hematopoietic stem cell transplants, a vital area for many patients with hematological malignancies.

Professional Recognition and Membership:

  • Council Memberships: Dr. He has served as a Council Member for both the Experts Committee of the China Marrow Donor Program and The Chinese Medical Society of Organ Transplantation, indicating peer recognition and trust in his expertise.
  • International Membership: His membership in the American Society of Histocompatibility and Immunogenetics shows his engagement with the global scientific community.

Community Impact:

  • Marrow Donor Program: His long-term involvement with the China Marrow Donor Program reflects his commitment to enhancing donor registries and improving transplantation outcomes, directly benefiting patients and the broader community.
  • Training and Mentorship: As a Doctoral Supervisor, Dr. He plays a significant role in training the next generation of medical professionals and researchers, amplifying his impact on community health.

Innovative Research Contributions:

  • NGS and mNGS: His recent work using next-generation sequencing (NGS) and metagenomic NGS for pathogen identification demonstrates his engagement with cutting-edge technologies to improve clinical decision-making and patient outcomes.

In conclusion, Dr. Jun He’s distinguished career, significant research contributions, leadership roles, and dedication to community health make him a highly deserving candidate for the Research for Community Impact Award.

📊🔬Notable Publication:

    • Authors: Xu, J., Zhou, P., Liu, J., Ma, Y., He, J.
    • Journal: Infectious Diseases and Therapy
    • Year: 2023

 

    • Authors: Jiang, X., Yuan, X., Li, Y., Bao, X., He, J.
    • Journal: HLA
    • Year: 2023

 

    • Authors: Wang, L., Ji, K., Chen, L., Wu, X., He, J.
    • Journal: Frontiers in Immunology
    • Year: 2022

 

    • Authors: Zhou, S., Ma, X., Ma, C., Wu, X., Qin, S.
    • Journal: Bone Marrow Transplantation
    • Year: 2023

 

    • Authors: Cheng, Y., He, J., Zuo, B., He, Y.
    • Journal: Discover Oncology
    • Year: 2024